187 related articles for article (PubMed ID: 37044261)
1. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids.
Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T
J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261
[TBL] [Abstract][Full Text] [Related]
2. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
4. Attitudes and Beliefs about Hysterectomy in Patients with Uterine Fibroids.
Duyar S; Tsai S; Milad MP; Chaudhari A
J Minim Invasive Gynecol; 2023 Oct; 30(10):797-804. PubMed ID: 37245673
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
6. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
[TBL] [Abstract][Full Text] [Related]
7. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
8. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry.
Anchan RM; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL; Spies JB
J Womens Health (Larchmt); 2023 Apr; 32(4):423-433. PubMed ID: 36637808
[No Abstract] [Full Text] [Related]
10. Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.
Manyonda I; Belli AM; Lumsden MA; Moss J; McKinnon W; Middleton LJ; Cheed V; Wu O; Sirkeci F; Daniels JP; McPherson K;
N Engl J Med; 2020 Jul; 383(5):440-451. PubMed ID: 32726530
[TBL] [Abstract][Full Text] [Related]
11. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
12. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
[TBL] [Abstract][Full Text] [Related]
13. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
Sirkeci F; Moss J; Belli AM; McPherson K; Daniels J; Manyonda I; Middleton L; Cheed V; Wu O; Lumsden MA;
Int J Gynaecol Obstet; 2023 Feb; 160(2):492-501. PubMed ID: 36511801
[TBL] [Abstract][Full Text] [Related]
14. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study.
Chen J; Li Y; Wang Z; McCulloch P; Hu L; Chen W; Liu G; Li J; Lang J;
BJOG; 2018 Feb; 125(3):354-364. PubMed ID: 28421665
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.
Thao V; Moriarty JP; Stewart EA; Borah BJ
J Minim Invasive Gynecol; 2023 Oct; 30(10):813-819. PubMed ID: 37286130
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a hysteroscopic tissue removal system device for hysteroscopic myomectomy on patients' quality of life: a randomized clinical trial.
Tam T; Juarez L
BMC Womens Health; 2023 Oct; 23(1):541. PubMed ID: 37848865
[TBL] [Abstract][Full Text] [Related]
18. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
19. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
20. Twin pregnancies with uterine fibroids are not at increased risk for obstetric complications: single center cohort study.
Kim ML; Hong K; Kim S; Lee MJ; Shim SS; Hur YM; Shin JS
BMC Pregnancy Childbirth; 2020 Apr; 20(1):222. PubMed ID: 32295544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
